Dr. Donald R. Branch received his Bachelors’ degrees in Chemistry and Cell & Molecular Biology from San Francisco State University. He obtained his PhD in Immunology working under Larry J. Guilbert at the University of Alberta and he completed his Postdoctoral Fellowship under Dr. Gordon B. Mills, focused on signal transduction, in the Department of Immunology at the University of Toronto. In the 1980s, working with Dr. Lawrence D. Petz at the City of Hope National Medical Center, Dr. Branch discovered and coined the term “mixed hematopoietic chimerism” following marrow ablative bone marrow transplant. He was the inventor of ZZAP (W.A.R.M.), first reported the effects of DTT on RBC antigens and advocated its use in antibody investigations, and was a pioneer in the development and use of the monocyte monolayer assay (MMA) in transfusion medicine. Dr. Branch has recently been working on small-molecule drugs that inhibit phagocytosis. He has recently identified two lead molecules that will be further evaluated for their ability to ameliorate immune cytopenias using a mouse model of immune thrombocytopenia. Dr. Branch has published more than 180 original research papers and has received numerous awards of distinction for his work in transfusion and transplantation medicine. Dr. Branch is currently a Professor in both Medicine and Laboratory Medicine and Pathobiology at the University of Toronto and a Senior Scientist at the Centre for Innovation with the Canadian Blood Services.